Skip to main navigation menu Skip to main content Skip to site footer
##common.pageHeaderLogo.altText##

Special article

Vol. 140 No. 2930 (2010)

Retrospective research: what are the ethical and legal requirements?

  • V Junod
DOI
https://doi.org/10.4414/smw.2010.13041
Cite this as:
Swiss Med Wkly. 2010;140:w13041
Published
19.07.2010

Summary

Retrospective research is conducted on already available data and/or biologic material. Whether such research requires that patients specifically consent to the use of “their” data continues to stir controversy. From a legal and ethical point of view, it depends on several factors. The main criteria to be considered are whether the data or the sample is anonymous, whether the researcher is the one who collected it and whether the patient was told of the possible research use. In Switzerland, several laws delineate the procedure to be followed. The definition of “anonymous” is open to some interpretation. In addition, it is debatable whether consent waivers that are legally admissible for data extend to research involving human biological samples. In a few years, a new Swiss federal law on human research could clarify the regulatory landscape. Meanwhile, hospital-internal guidelines may impose stricter conditions than required by federal or cantonal law. Conversely, Swiss and European ethical texts may suggest greater flexibility and call for a looser interpretation of existing laws. The present article provides an overview of the issues for physicians, scientists, ethics committee members and policy makers involved in retrospective research in Switzerland. It aims at provoking more open discussions of the regulatory problems and possible future legal and ethical solutions.

References

  1. WMA: The world medical association declaration on ethical considerations regarding health databases. 2002: http://www.wma.net/en/30publications/10policies/d1/index.html (accessed July 20, 2010).
  2. CIOMS: Council for international organizations of medical sciences. International ethical guidelines for biomedical research involving human subjects: http://www.cioms.ch/publications/guidelines/guidelines_nov_2002_blurb.htm (accessed July 20, 2010).
  3. Sobel ME: Ethical issues in molecular pathology: Paradigms in flux. Arch Pathol Lab Med. 1999;123:1076–8.
  4. Sobel ME, Wolman SR. The ethical uses of human tissues in research. Breast J. 1999;5:153–5.
  5. 321bis A: Swiss penal code. Available at: http://www.admin.ch/ch/f/rs/311_0/a321bis.html (accessed: July 20, 2010).
  6. OALSP: Ordinance regarding authorizations to lift professional secrecy for medical research (hereafter OALSP). Ordinance of the federal council (RS number 235.154) entered into force on July 1, 1993. http://www.admin.ch/ch/f/rs/c235_154.html (accessed July 20, 2010).
  7. Expert Commission: Federal expert commission for professional secrecy in medical research. Activity report for years 1998-2000: Http://www.Bag.Admin.Ch/org/02329/02359/index.Html?Lang=fr&download=m3wbpgdb/8ull6du36wenojq1nttjaxznqwfvp7yhmfhnapmmc7zi6rznqckkiv7f3d/bkbxrz6lhudzz8mmps2gpkfo (accessed July 14, 2009)..
  8. LPD: Swiss federal law on data protection: Http://www.Admin.Ch/ch/f/rs/c235_1.Html (accessed July 12, 2009).
  9. Geneva law on health: Loi sur la santé: Http://www.Geneve.Ch/legislation/rsg/f/rsg_k1_03.Html (accessed July 20, 2010).
  10. Expert Commission: Federal expert commission for professional secrecy in medical research. Activity report for years 2005-2007: Http://www.Bag.Admin.Ch/org/02329/02359/index.Html?Lang=fr&download=m3wbpgdb/8ull6du36wenojq1nttjaxznqwfvp7yhmfhnapmmc7zi6rznqckkiz9g3x7bkbxrz6lhudzz8mmps2gpkfo (accessed July 14, 2009).
  11. Allen J, McNamara B: Reconsidering the value of consent in biobank research. Bioethics 2009 [Epub ahead of print].
  12. Capron AM, Mauron A, Elger BS, Boggio A, Ganguli-Mitra A, Biller-Andorno N. Ethical norms and the international governance of genetic databases and biobanks: Findings from an international study. Kennedy Inst Ethics J. 2009;19:101–24.
  13. Elger B. Consent to research involving human biological samples obtained during medical care; in Elger B, Biller-Andorno N, Mauron A, Capron AM (eds): Ethical issues in governing biobanks: Global perspectives. London, Ashgate, 2008, pp. 89–120.
  14. Hansson MG, Dillner J, Bartram CR, Carlson JA, Helgesson G. Should donors be allowed to give broad consent to future biobank research? Lancet Oncol. 2006;7:266–9.
  15. Hofmann B. Broadening consent – and diluting ethics? J Med Ethics. 2009;35:125–9.
  16. ESHG: Data storage and DNA banking for biomedical research: Technical, social and ethical issues. Recommendations of the European society of human genetics. Eur J Hum Genet. 2003;11(Suppl 2):S8–S10.
  17. SAMS: Directive on biobanks, obtainment, preservation and utilisation of human biological material. Basel, SAMS, 2006.
  18. Data Protection Commissioner: Data protection commissioner’s 2008-2009 report: http://www.edoeb.admin.ch/dokumentation/00445/00509/01551/index.html?lang=de (accessed July 20, 2010).
  19. COE: Council of Europe. Rec(2006)4 of the committee of ministers to member states on research on biological materials of human origin: https://wcd.coe.int/ViewDoc.jsp?id=977859 (accessed July 20, 2010).
  20. Elger BS, Caplan AL. Consent and anonymization in research involving biobanks: Differing terms and norms present serious barriers to an international framework. EMBO Rep. 2006;7:661–6.
  21. Expert Commission: Federal expert commission for professional secrecy in medical research. Activity report for years 2001 to 2004: Http://www.Bag.Admin.Ch/org/02329/02359/index.Html?Lang=fr&download=m3wbpgdb/8ull6du36wenojq1nttjaxznqwfvp7yhmfhnapmmc7zi6rznqckkiv7f3d9bkbxrz6lhudzz8mmps2gpkfo (accessed July 14, 2009).
  22. HUG: Hug implementing guideline: Hug intranet. Available: Address request to K. Marescotti.
  23. Authorization: Initial general authorization granted to the hug on July 10, 2001, http://www.Admin.Ch/ch/f/ff/2001/3002.Pdf, and its renewed version of 2007, at http://dirmed.Hug-ge.Ch/_library/pdf/autorisationgenerale_2008_2012.pdf.
  24. FMH: Conduct code of the Swiss medical association (FMH): http://www.fmh.ch/fr/fmh/bases_legales/code_deontologie.html (accessed July 20, 2010).
  25. HUG: Directives du comité de direction sur le prélèvement et/ou l’utilisation d’organes, de tissues, de cellules ou tout autre matériel biologique sur l’être humain à des fins de recherche ou d’enseignement. Genève, Hôpitaux Universitaires de Genève, 2004.
  26. Swiss federal government: Swiss federal government: Steps of the law project: Http://www.Parlament.Ch/f/suche/pages/geschaefte.Aspx?Gesch_id=20070072 (accessed July 20, 2010).
  27. WMA: World medical association. Declaration of Helsinki, adopted by the 59th wma general assembly, Seoul, October 2008: Http://www.Wma.Net/e/policy/b3.Htm (accessed July 14, 2009).
  28. WMA: World medical association. Declaration of Helsinki, adopted by the 52nd world medical association general assembly, Edinburgh, Scotland.
  29. WHO: Who’s guideline for obtaining informed consent for the procurement and use of human tissues in preparing a research project proposal third edition – 2000: Http://www.Who.Int/reproductivehealth/topics/ethics/human_tissue_use.Pdf or (entire document): Http://www.Who.Int/reproductivehealth/topics/ethics/human_tissue_use_guide_serg/en/index.Html (accessed July 14, 2009).
  30. Hansson MG. Combining efficiency and concerns about integrity when using human biobanks. Stud Hist Philos Biol Biomed Sci. 2006;37:520–32.
  31. Eriksson S, Helgesson G. Potential harms, anonymization, and the right to withdraw consent to biobank research. Eur J Hum Genet. 2005;13:1071–6.